rs1553463718
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PP2PP3_ModeratePP5
The NM_001040142.2(SCN2A):c.5551C>T(p.Arg1851Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001040142.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- developmental and epileptic encephalopathy, 11Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- episodic ataxia, type 9Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- seizures, benign familial infantile, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- benign familial neonatal-infantile seizuresInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- malignant migrating partial seizures of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN2A | ENST00000375437.7 | c.5551C>T | p.Arg1851Trp | missense_variant | Exon 27 of 27 | 5 | NM_001040142.2 | ENSP00000364586.2 | ||
| SCN2A | ENST00000631182.3 | c.5551C>T | p.Arg1851Trp | missense_variant | Exon 27 of 27 | 5 | NM_001371246.1 | ENSP00000486885.1 | ||
| SCN2A | ENST00000283256.10 | c.5551C>T | p.Arg1851Trp | missense_variant | Exon 27 of 27 | 1 | ENSP00000283256.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Seizures, benign familial infantile, 3 Pathogenic:1
- -
Inborn genetic diseases Uncertain:1
The c.5551C>T (p.R1851W) alteration is located in exon 27 (coding exon 26) of the SCN2A gene. This alteration results from a C to T substitution at nucleotide position 5551, causing the arginine (R) at amino acid position 1851 to be replaced by a tryptophan (W). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant was reported in an individual with features consistent with SCN2A-related disorders (Fernández-Marmiesse, 2019). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Complex neurodevelopmental disorder Uncertain:1
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2019-01-29 and interpreted as Variant of Uncertain significance. Variant was initially reported on 2017-09-25. The reporting laboratory might also submit to ClinVar. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at